Good news .. You can take medicine for the pandemic at home || latest updates – our health - Health Tips Galaxy

Breaking

Home Top Ad

Post Top Ad

Tuesday, 11 May 2021

Good news .. You can take medicine for the pandemic at home || latest updates – our health





The Drugs Controller General of India (DCGI) has recently approved a new drug by the Defense Research and Development Organization (DRDO) for emergency use on Co * wid-19 patients.

Developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), DRDO’s laboratory in collaboration with Dr. Reddy’s Laboratories, Hyderabad ) Also reduces dependence on.

It is not a reconstituted drug, and the method by which it is made is unique. The drug is selected in virus-infected cells and reportedly reduces the energy supply to the virus. Therefore, the virus does not multiply automatically, which helps to gradually reduce the infection and viral load. Eventually, the cells recover.

The Phase One and Phase Two trial results, on the basis of which DCGI has granted emergency utilization authority, clearly show a great deal of confidence in this. However, after the completion of the third phase trial reports, we will get a clear picture of what the risk-benefit analysis of this new drug is.

The manufacturers of this drug claim that it is taken only by infected cells. However, it is not clear whether this drug has the ability to kill some common cells or cause harm to them or have no effect on them.

We only know if this drug has any side effects when tested on adults. Therefore, in phase 3 efforts, as the number of volunteers increases, we will have a better understanding of how this drug interacts with human cells.

When determining the risks and benefits, the most important thing is to assess whether the benefits outweigh the risks. Currently, it is prescribed to people with severe Kovid-19 infection. After using this drug, the probability of recovery in these patients is much higher than those kept in standard care therapy. If, however, it persists even after the third stage trial, and there are fewer or fewer side effects, this drug will clearly help most patients.

This also applies to the antiviral drugs and antibiotics we commonly use. All of these drugs have side effects that affect normal cells, but the harm is far less than the benefit we get from them.

Broadly, you can classify 2-DG as antiviral, but in a real sense, it is not antiviral because it does not kill the virus. It only integrates within the cell and reduces the growth material needed for the virus to grow. From a scientific point of view, it cannot be called antiviral.

Currently, the drug comes in powder form, in sachets, taken orally by dissolving in water. As it is approved for emergency use only, it should only be used in the care of the supervising physicians. According to research, a high percentage of patients treated with the drug tested positive for RV-PCR.



No comments:

Post a Comment

Post Bottom Ad

Pages